.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2019-002824-34-FR

Enrollment

100

Registered

2019-07-22

Start date

2019-10-08

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: AMOXICILLIN CAS Number: 26787-78-0

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: . Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 50 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 50

Exclusion criteria

Exclusion criteria: .

Design outcomes

Primary

Measure	Time frame
Main Objective: .;Secondary Objective: .;Primary end point(s): .;Timepoint(s) of evaluation of this end point: .	—

Secondary

Measure	Time frame
Secondary end point(s): .;Timepoint(s) of evaluation of this end point: .	—

Countries

France

Contacts

Public ContactLise LACLAUTRE

CHU de Clermont-Ferrand

promo_interne_drci@chu-clermontferrand.fr+33473754963

Outcome results